This service specification also covers children with suspected Multiple Sclerosis (MS) or equally rare ‘MS-like’, recurrent acquired demyelinating syndromes (ADS) or who have had a first demyelination episode and have a high risk of relapse which require similar treatments, including:

• Neuromyelitis Optica Spectrum Disorder (NMO, NMOSD) and other AQP4 antibody associated demyelination;
• Myelin Oligodendrocyte Glycoprotein (MOG) antibody associated relapsing demyelination and
• Other forms of recurrent relapsing demyelination.